Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Aug 31;46(4):449-55.
doi: 10.3349/ymj.2005.46.4.449.

Obesity, insulin resistance and cancer risk

Affiliations
Review

Obesity, insulin resistance and cancer risk

Sun Ha Jee et al. Yonsei Med J. .

Abstract

Obesity is a known cause of metabolic syndrome which includes Type II diabetes, hypertension, and dyslipidemia. It is well documented that insulin resistance contributes to the mortality and the incidence of metabolic syndromes including central obesity, dyslipidemia, hyperglycemia and hypertension. Both obesity and diabetes are emerging topics for researchers to consider as having a possible causal association with cancer since the two factors have been viewed as risk factors for cancer. The present paper introduced the hypothesis of a possible causal relationship between obesity, insulin resistance and cancer and reviews relevant existing studies in this area. More efforts and studies are needed to clarify the mechanisms and the common risk factors which might be incorporated into interventions to prevent cancer and cardiovascular diseases as top causes of death.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Prevalence of obesity in Korean men.
Fig. 2
Fig. 2
Increased cancer risk through insulin resistance: a multi-dimensional model.
Fig. 3
Fig. 3
Hazard ratios of diabetes versus non-diabetes on various cancers in Korean men and women. Source: Jee et al. JAMA 2005;293:194-202.
Fig. 4
Fig. 4
Hazard ratios for all cancer deaths by fasting serum glucose levels in Korean men according to body mass index, 1993-2002. Source: Jee et al. JAMA 2005;293:194-202.

References

    1. Garrison RJ, Higgins MW, Kannel WB. Obesity and coronary heart disease. Curr Opin Lipidol. 1996;7:199–202. - PubMed
    1. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716. - PubMed
    1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–591. - PubMed
    1. Komninou D, Ayonote A, Richie JP, Jr, Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 2003;228:396–405. - PubMed
    1. Renehan AG, Howell A. Preventing cancer, cardiovascular disease, and diabetes. Lancet. 2005;365:1449–1451. - PubMed

Publication types